EYPT
EyePoint Pharmaceuticals, Inc.
$14.28
AlphaVal Unavailable
AlphaVal: EYPT has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.